Rituximab for rapidly progressive juvenile systemic sclerosis.
Rheumatology (Oxford)
; 59(12): 3793-3797, 2020 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-32442284
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Antirheumatic Agents
/
Rituximab
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2020
Document type:
Article
Country of publication:
Reino Unido